{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-084627","form_type":"8-K","ticker":"TVRD","cik":"0001346830","company_name":"Tvardi Therapeutics, Inc.","filed_at":"2026-07-17T20:07:52+00:00","discovered_at":"2026-07-17T20:09:00.606690+00:00","generated_at":"2026-07-17T20:09:10.898639+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Tvardi Therapeutics increases ATM offering by up to $9.7M","bullets":["Filed prospectus supplement to increase ATM offering capacity by $9,689,765 in common stock.","Prior 12-month sales under existing program: 3,110,769 shares for ~$11.0M gross proceeds.","Offering subject to 'baby shelf' rule; non-affiliate market value $62.2M based on 12.4M shares at $5.00.","No additional shares will be sold under prior prospectus after supplement date.","Legal opinion from Cooley LLP filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-084627","json":"https://secwatch.observer/filing/0001104659-26-084627.json","markdown":"https://secwatch.observer/filing/0001104659-26-084627.md","text":"https://secwatch.observer/filing/0001104659-26-084627.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926084627/0001104659-26-084627-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926084627/tm2620743d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-17T20:09:10.898639+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}